FDA Inspection 1162090 — OneBlood Inc.
The FDA completed an inspection of OneBlood Inc. on Feb 10, 2022 in Jacksonville Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 10, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Jacksonville Beach, FL (United States)